1 | The clinical impact of glucose-6-phosphate dehydrogenase deficiency in patients with sickle cell disease. (Karafin MS, Fu X, D'Alessandro A, Thomas T, Hod EA, Zimring JC, Field JJ, Francis RO) Curr Opin Hematol 2018 Nov;25(6):494-499 15 Citations |
1 | Neonatal hyperbilirubinemia in infants with G6PD c.563C > T Variant. (Moiz B, Nasir A, Khan SA, Kherani SA, Qadir M) BMC Pediatr 2012 Aug 20;12:126 19 Citations |
3 | High prevalence of Dapsone-induced oxidant hemolysis in North American SCT recipients without glucose-6-phosphate-dehydrogenase deficiency. (Olteanu H, Harrington AM, George B, Hari PN, Bredeson C, Kroft SH) Bone Marrow Transplant 2012 Mar;47(3):399-403 17 Citations |
1 | Moderate G6PD deficiency increases mutation rates in the brain of mice. (Felix K, Rockwood LD, Pretsch W, Nair J, Bartsch H, Bornkamm GW, Janz S) Free Radic Biol Med 2002 Apr 01;32(7):663-73 21 Citations |
1 | Three new exon 10 glucose-6-phosphate dehydrogenase mutations. (Beutler E, Westwood B, Melemed A, Dal Borgo P, Margolis D) Blood Cells Mol Dis 1995;21(1):64-72 22 Citations |
1 | Progressive peroneal muscular atrophy (Charcot-Marie-Tooth disease) associated with beta-thalassemia trait and glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. A clinical and nerve biopsy case. (Inzitari D, Rizzuto N, Antuono P, Sità D) Ital J Neurol Sci 1981 Aug;2(3):269-74 |